Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Market Overview The global podiatry instruments market is valued at approximately $1.2 billion in 2024 and is projected to...
-
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- The global anti-parasite products market was valued at approximately $12 billion in 2024 and is projected to reach $18 billion...
-
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Patient Transfer Robot Market Research Report The global patient transfer robot market is valued at approximately $1.2 billion...
-
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- The global Medical X-ray Film Processing Device Market was valued at $1.2 billion in 2024 and is projected to grow at a CAGR of...
-
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- The Molecular Targeted Therapy Market is experiencing robust growth, with an estimated valuation of $127 billion in 2024,...
-
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Market Overview The global thinning machine market is valued at approximately $2.1 billion in 2024 and is forecast to grow at...
-
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Potential Therapy Equipment Market Research Report As of 2024, the global market for potential therapy equipment is valued at...
-
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Market Overview The global interventional pulmonology device market is projected to reach USD 6.2 billion in 2024 and is...
-
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- The global crystal and oscillators market is poised for steady growth, expected to rise from approximately USD 7.5 billion in...
-
EXTON, PA, June 02, 2025 (GLOBE NEWSWIRE) -- Just over six months into its dual launch across Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (axSpA), UCB’s Bimzelx (bimekizumab) is...